menu ☰
menu ˟

NICE Guidance

Smoking cessation in secondary care: Acute, maternity and mental health services (PH 48)

National Institute for Health and Clinical Excellence (NICE) Smoking Cessation Stopping smoking at any time has considerable health benefits and for people using secondary care services, there are additional advantages including shorter hospital stays and ...

Myocardial Infarction- Secondary prevention (CG 172)

National Institute for Health and Clinical Excellence (NICE) Secondary prevention, Primary care, Secondary care, Patients, Myocardial infarction, Heart attack This clinical guideline (published November 2013) updates and replaces NICE clinical guideline 4 ...

Tobacco: Harm-reduction approaches to smoking (PH 45)

National Institute for Health and Clinical Excellence (NICE) Tobacco smoke Nicotine inhaled from smoking tobacco is highly addictive. But it is primarily the toxins and carcinogens in tobacco smoke – not the nicotine – that cause illness and death. The be ...

WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension (MTG13)

National Institute for Health and Clinical Excellence (NICE) Using WatchBP Home A in the NHS for opportunistically detecting asymptomatic atrial fibrillation during the measurement of blood pressure by primary care professionals, is backed by the NICE gui ...

Preventing Type 2 Diabetes: Risk Identification and Interventions for Individuals at High Risk (PH 38)

National Institute for Health and Clinical Excellence (NICE) Risk assessment for diabetes This guidance is for everyone who is involved identifying people at high risk of type 2 diabetes and in preventing or delaying its onset.. This includes GPs, nurses ...

Rivaroxaban for the Prevention of Stroke and Systemic Embolism in People with Atrial Fibrillation

National Institute for Health and Clinical Excellence (NICE) Stroke prevention treatment NICE recommends rivaroxaban as a possible treatment to prevent stroke and systemic emblism in some people with atrial fibrillation. NICE looks at how well treatments ...

Improving identification and consent rates for organ donation: NICE Clinical Guidance 135

National Institute for Health and Clinical Excellence (NICE) Organ donation This clinical guideline offers evidence-based advice on identifying potential organ donors as a result of brainstem death or circulatory death. It also gives advice on obtaining c ...

Osteoarthritis: National clinical guideline for care and management in adults

National Institute for Health and Clinical Excellence (NICE) The care and management of osteoarthritis in adults The advice in the NICE guideline covers the treatment, advice and support that people who have osteoarthritis should be offered by their healt ...

Preventing type 2 diabetes: population and community interventions (PH 35)

National Institute for Health and Clinical Excellence (NICE) Diabetes This guidance is aimed at those working in national and local public health services. This includes: directors and commissioners, GPs, practice nurses, dietitians, public health nutriti ...

Psychosis with coexisting substance misuse: assessment and management in adults and young people.

This guideline offers best practice advice on the assessment and management of people with psychosis and coexisting substance misuse. Psychosis is a condition that affects a personâ?Ts mental state, including their thoughts, mood and behaviour. The sympto ...

Diabetic foot- inpatient management of people with diabetic foot ulcers and infection: NICE Clinical Guidance 119

National Institute for Health and Clinical Excellence (NICE) DIABETES MELLITUS, FOOT HEALTH, INPATIENT SERVICES The feet of people with diabetes can be affected by neuropathy, peripheral arterial disease, foot deformity, infections, ulcers and gangrene. D ...

Liraglutide for the treatment of type 2 diabetes mellitus

National Institute for Health and Clinical Excellence (NICE) DIABETES MELLITUS, MEDICAL TREATMENT NICE recommends liraglutide taken at a dose of 1.2 mg once a day as a possible treatment for some people with type 2 diabetes mellitus. However, NICE does no ...

Looked-after Children and Young People (PH 28)

National Institute for Health and Clinical Excellence (NICE) and the Social Care Institute for Excellence (SCIE) CHILD, EDUCATION, HEALTH, PHYSICAL ACTIVITY, QUALITY OF LIFE, SOCIAL FACTOR, WELLBEING, YOUNG PEOPLE This joint guidance from NICE and the Soc ...

Prevention of Cardiovascular Disease (PH 25)

National Institute for Health and Clinical Excellence Guidance on the prevention of cardiovascular disease at the population level The guidance is for government, the NHS, local authorities, industry and all those whose actions influence the population’s ...

Alcohol-use Disorder: Preventing Harmful Drinking (PH 24)

National Institute for Health and Clinical Excellence Harmful drinking, Alcohol consumption, Drugs misuse, Education, Prevention This guidance is for government, industry and commerce, the NHS and all those whose actions affect the population’s attitude t ...

Promoting Mental Wellbeing at Work (PH 22)

National Institute for Health and Clinical Excellence Guidance to promote mental wellbeing through productive and healthy working conditions The guidance is for those who have a direct or indirect role in, and responsibility for, promoting mental wellbein ...

Workplace Interventions to Promote Smoking Cessation (PH 5)

National Institute for Health and Clinical Excellence (NICE) Guidance on interventions to promote smoking cessation in the workplace Reducing smoking and tobacco-related harm is a key government strategy for improving the health of people in England and r ...

Smoking Cessation Services (PH 10)

National Institute for Health and Clinical Excellence (NICE) Guidance on smoking cessation services in primary care Reducing the prevalence of smoking among people in routine and manual groups, some minority ethnic groups and disadvantaged communities wil ...

Physical Activity and the Environment (PH 8)

National Institute for Health and Clinical Excellence (NICE) Guidance on the promotion and creation of physical environments that support increased levels of physical activity This guidance offers the first national, evidence-based recommendations on how ...

Management of Long-term Sickness and Incapacity for Work (PH 19)

National Institute for Health and Clinical Excellence (NICE) MANAGEMENT, SICKNESS ABSENCE, TRAINING, EMPLOYER, EMPLOYEE This guidance is for all those who manage long-term (or recurring short- or long-term) sickness absence and incapacity, including emplo ...

IPH Logo

Filter by content type:

Filter by catalogues: